Oncological and functional outcome of ultra low colo – anal anastomosis with and without intersphincteric resection for low rectal cancer R.Ruppert Städt.

Slides:



Advertisements
Similar presentations
Surgical Treatment of the Low (Distal Third) Rectal Cancer
Advertisements

Neoadjuvant therapy for Rectal cancer
Taunton SpR Training Day 7th December 2012 Early rectal cancer
Carcinoma of the Cardia: Is there progress in the management of non-Barrett’s cancer Spanish Association of Surgeons Madrid 11 November 2002 The University.
Multimodality Therapy of Rectal Cancer Robert D. Madoff, MD University of Minnesota.
T Staging: Rectal cancer T1 invades submucosa T2 invades muscularis propria T3 invades subserosa or perirectal tissues T4 invades peritoneum, organs or.
Rectal Cancer: A Complete Clinical Response…Now what?
Age as a prognostic factor for head and neck squamous cell carcinoma: should older patients be treated differently? Udi Cinamon 1, Michael P. Hier 2, Martin.
JHSGR Neoadjuvant Therapy For Rectal Cancer Dr Chris TL Cheng Princess Margaret Hospital.
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.
Slawomir Marecik, MD, FACS, FASCRS Advocate Lutheran General Hospital, Park Ridge, IL Clinical Assistant Professor University of Illinois, Chicago, USA.
Defining the Colorectal Surgeons role in patients with colorectal cancer and limited metastatic disease Jose G. Guillem, MD, MPH Department of Surgery.
Neoadjuvant Adjuvant Curative Palliative Neoadjuvant Radiation therapy the results of a phase III study from Beijing demonstrated a survival benefit.
Management of early rectal carcinoma Joint Hospital Surgical Grand Round Jeren Lim United Christian Hospital.
Treatment of Early Malignant Rectal Polyp
Management of Locally Advanced Rectal Cancer Joint Hospital Surgical Grand Round Pamela Youde Nethersole Eastern Hospital Dr. YH Ling 19 May 2007.
Slawomir Marecik, MD, FACS Advocate Lutheran General Hospital, Park Ridge, IL Clinical Assistant Professor University of Illinois, Chicago, USA.
Dept Surgery, Colorectal unit University Hospital, Uppsala, Sweden
Robotic LAR with Transanal Extraction Alessio Pigazzi City of Hope Duarte, CA.
Brendan Moran Basingstoke OCTOBER 2008
Preoperative CCRT in Colorectal Cancer 嘉義長庚醫院 大腸直腸外科 葉重宏.
A. MONTORI M.D. F.A.C.S. PROFESSOR OF SURGERY UNIVERSITY OF ROME “LA SAPIENZA” President of EAcSS HOW TO AVOID MAJOR SURGERY IN RECTAL CANCER MSO-MTCC.
Sphincter preserving surgery after preoperative treatment for ultra-low rectal carcinoma. A French multicenter prospective trial: GRECCAR 1 P Rouanet,
Specialist surgery “Some surgeons perform less than optimal surgery. Some are less competent technically than their colleagues; and some fail to supervise.
Ultra-Low Sphincter Saving Procedures -
What to do with Anastomotic Stricture Gustavo Plasencia MD, FACS, FASCRS.
Crohn’s Colitis Patients Should Never Be Offered an Ileoanal Pouch Asher Kornbluth, MD Clinical Professor of Medicine The Henry D. Janowitz Division of.
What is the Preferable Treatment Option for T1/T2 Low Rectal Cancer? Christopher H. Crane, M.D. Program Director, GI Section Department of Radiation Oncology.
1 Recent trends in colorectal cancer in Norway: incidence, management and outcomes Arne Wibe, MD, PhD Professor of Surgery St. Olavs Hospital Trondheim,
Colonic stenting for intestinal obstruction due to left colon and rectal cancer Dr Sherman Lam TKOH JHSGR 26 April 2014.
SYNCHRONOUS COLORECTAL AND LIVER RESECTION J Peter A Lodge MD FRCS HPB and Transplant Unit St James’s University Hospital Leeds LS9 7TF 2006 Association.
CR07 results and informed patient consent David Sebag-Montefiore Leeds Cancer Centre.
TME trial TME radiotherapy 5 x 5 Gy TME alone randomisation n = 1861 resectable rectal carcinoma if CRM+: 50 GY.
Transanal Endoscopic Operation Indication – Technique – Results M. Sailer Department of Surgery Bethesda Hospital – Hamburg, Germany.
Preoperative chemoradiotherapy and postoperative chemotherapy with 5-FU and oxaliplatin versus 5-FU alone in locally advanced rectal cancer: First results.
Rectal Cancer: French Prodige Study: Best of ASCO, Beirut, July 2009 Prof Eric Van Cutsem, MD, PhD Digestive Oncology Leuven, Belgium.
RT with TME surgery ? OUTLINEOUTLINE. Prostate Seminal vessels Neurovascular bundle Denonvilliers Fascia “holy plane” (Fascia rectalis) Total Mesorectal.
Pathologist and Prognosis in Colorectal Cancer Surgery. Dr Bryan F Warren Consultant Gastrointestinal Pathologist Oxford M62 Course 2004.
Exit Examinations European view M62 Coloproctolgy course, Huddersfield Lars Påhlman Dept. Surgery, Colorectal unit University Hospital, Uppsala, Sweden.
Nazem Shams, Malak Shawki Mansoura University Oncology Centre (OCMU)
Prognosis of colon cancer compared with rectal cancer. Where lies the difference? Bjørn S. Nedrebø Stavanger University Hospital.
* AP: Anteroposterior, Lat: Lateral Tumor diameter, tumor length, depth of penetration, distance from the anal verge, deep and narrow pelvic dimension.
Local recurrence after rectal cancer resection is strongly related to the plane of surgical (PoS) dissection and is further reduced by pre-operative short.
T Staging: Rectal cancer T1 invades submucosa T2 invades muscularis propria T3 invades subserosa or perirectal tissues T4 invades peritoneum, organs or.
Adjuvant chemotherapy in Rectal Cancer?. What is the evidence for adjuvant chemotherapy? Do patients achieving a pathological complete response need chemotherapy?
Management of the primary in Stage IV colorectal cancer Erin Kennedy, MD, PhD, FRCSC Colorectal Surgery Mount Sinai Hospital University of Toronto.
Quality of Life and Functional Results Following Pelvic Exenteration Erin Kennedy September 19, 2015.
J. Lujan, G. Valero, Q. Hernandez, A. Sanchez, M.D. Frutos and P. Parrilla. British Journal of Surgery, September 2009.
Mamoun A. Rahman Surgical SHO Mr Osborne’s team. Introduction Blood transfusion: -Preoperative ( elective) -Intra/postoperative ( urgent) Blood transfusion.
Radical surgery is the preferable treatment option for T1- 2/N0 low rectal cancer Jose G. Guillem, MD, MPH Department of Surgery Memorial Sloan Kettering.
Preliminary Results of the MRC CR07 / NCIC CO16 Randomized Trial Short course pre-op vs selective post-op chemo-RT for rectal cancer Local Recurrence after.
Dr Mark Saunders Christie Hospital and Paterson Institute of Cancer Research “ Rectal cancer radiotherapy – why do we give it and how do we do it?”
Basingstoke Colorectal The Particular Problem of Low Rectal Cancer Brendan Moran Basingstoke 4 th East-West Colorectal Days Hungary 2008.
Role of MRI in Primary Rectal Cancer Staging and Management
Identification of localized rectal cancer (RC) patients (pts) who may NOT require preoperative (preop) chemoradiation (CRT). D. Roda 1, M. Frasson 2, E.
Addition of Chemotherapy to Preoperative Radiotherapy Improves Outcomes in Rectal Cancer Slideset on: Bosset JF, Calais G, Mineur L, et al. Enhanced tumorocidal.
Laparoscopic surgery for rectal cancer What is the evidence?
Karcinom rektuma- management
Joint Hospital Surgical Grand Round Dr Stewart Chan Kwong Wah Hospital
National Bowel Cancer Audit
盧建璋, 陳鴻華, 李克釗, 胡萬祥, 張家駱, 蔡鎧隆, 林岳民, 鄭功全, 吳昆霖
Antegrade enema after TME for rectal cancer: the last chance to avoid definitive colostomy for refractory LARS and fecal incontinence.
Dr Jessica Jenkins Consultant Oncologist
Short-term Outcomes of Transanal Total Mesorectal Excision
PRESENTATOR: MD VƯƠNG NHẤT PHƯƠNG. HO CHI MINH CITY ONCOLOGY HOSPITAL
Effect of Neoadjuvant Concurrent Chemoradiotherapy on Locally Advanced Middle and Low Rectal Cancer— A Propensity Score Matching Study 官泰全,林春吉,楊純豪,姜正愷,林宏鑫,藍苑慈,
The STAR-TREC Trial SIV Presentation
Developments in Colorectal Cancer
Presentation transcript:

Oncological and functional outcome of ultra low colo – anal anastomosis with and without intersphincteric resection for low rectal cancer R.Ruppert Städt. Klinikum München GmbH Klinikum – NEUPERLACH Klinik für Allgemein und Viszeralchirurgie endokrine Chirurgie und Coloproktologie Teaching hospital of the Ludwigs Maximilians University Heads of Departement: Prof. N. Nüssler / Dr. R.Ruppert

40 % of all colorectal carcinomas are located in the rectum Rectum is defined as 16 cm upwards from anocutaneus line Rectal cancer Surgical Technique Sphincter saving procedures Abdominoperineal Resection (APR) Low anterior resection (LAR) Intersphincteric resection (ISR) Sphincter sacrificing procedure

Total mesorectal Exzision (TME) Sharp dissection under direct vision “plane” between visceral und parietale pelvic fascia Stelzner 1962 Heald 1982 Stelzner F (1962) Die gegenwärtige Beurteilung der Rectumresektion und Rectumamputation beim Mastdarmkrebs. Bruns Beitr 204:41 Heald RJ, Husband EM, Ryall RDH (1982) The mesorectum in rectal cancer surgery—the clue to pelvic recurrence? Br J Surg 69:613–616

Surgical options for rectal cancer in the lower third of the rectum Low anterior resection (LAR) / ISR abdominoperineal Resection (APR) Expected number : % Expected number : %

The Status of radical proctectomy and sphincter-sparing surgery in the United States Ricciardi, irnig,Madoff,Rothenberger,Baxter DCR 8, 2007:

Oncological Outcomes after Mesorectal Excision For Cure for Cancer of the Lower Rectum: Anterior vs Abdominoperineal Resection Wibe et al., Trondheim, DCR 2004, konsecutive patients between in 47 Hospitals in Norway Multivariate analyses of prognostic factors: APR (risc 1,3), age over 20y (3,1), UICC,

Julius von Hohenegg (1859 – 1940) „pull through procedure“ Wien klin.Wzschr : Schematischer Sagittalschnitt durch ein männliches Becken nach ausgeführter Durchziehmethode

Straight coloanal anastomosis Established by Sir Alan Parks 1974 Circular stapler / hand sewn TME Covering stoma

History of „intramural spread“ 1910: Hanley 1913: Cole case reports Large intramural tumor spread 5 cm rule for distal resection margin was establlished for avoiding local recurrence

1 cm rule ? 1995: Shirouzu –610 Pat. DIS: overall 10%, all cases less < 1cm –3,8% were curative cases –40% were palliativ cases (distant metastases) Pat. with DIS have an advanced cancer stage They have a worse overall survival but no increased local recurrence Conclusion : 1cm distal resection margin is adequat

CRM involvement APR versus AR APRAR Mercury < 6cm tumours n=282 33%13% Classic trial curative n= %10% Dutch TME trial curative n= %13% Norwegian audit 12%5% Trent pelican Basingstoke 21%10% CR 07 n= %8% The CRM is the most pognostic factor ( independent) not the distal resection margin (DIS)

Japanese Experience Saito N et al. Dis Colon Rectum hospitals 228 low rectal cancers < 5 cm from anal verge T 1 n=46, T 2 n= 78, T 3 n= 104 Neoadjuvant Radiotherapy 57 Local recurrence at 5 years: 7 % Disease free survival (DFS): 83 % at 5 years Good continence (Kirwan I –II): 68 %

French Experience – Eric Rullier, ESCP 2008 Nantes Results n = 300 CAAPartial ISRTotal ISRAPR Age ns Tumour stage T1/T2 22 %13 %10 %6 %0,001 T372 %76 %81 %51 % T46 %11 %9 %43 % Preop RT67 %86 %88 %79 %0,007 Distance to anal ring (cm) 21- 0,5- 10,001 Hand sewn37 %96 %100 %0,001 Level of anastomosis 3 cm2 cm1 cm0,001 Colonic pouch 62 %72 %83 %0,01

Oncological feasibility French experience - Eric Rullier, ESCP, Nantes 2008 n = 300 CAAp ISRt ISRAPR CRM (mm) 75460,07 R o resection 87 %88 %81 % ns Tumor stage I 43 %45 %46 %16 %0,005 II 22 %24 %26 %39 % III 35 %29 %30 %45 % ns

Oncological outcome French experience - Eric Rullier, ESCP 2008, Nantes n = 300 CAAP ISRT ISRAPR Follow up (month) ns Local recurrence 5559ns Overall recurrence 20 % 21 %36 %P = 0,07 Delay of recurrence (month) ns

5 year overall and DFS

Meta analysis of ISR Tilney & Tekkis Colorectal Disease series from 13 units 612 patients Mortality 1,6 % Leakage 10,5 % Local recurrence 9,5 % (0 – 31) 5y survival 81 % Radiotherapy: oncological benefit but worse functional outcome

Summary For oncological reasons, intersphincteric resection is safe and should be offered to all patients as often it is possible.

Functional outcome ? How is continence influenced by intersphincteric resection ? Quality of life ?

Sphincter function 1. Internal anal sphincter – resting pressure 2. External anal sphincter - squeeze pressure

Intersphincteric resection Physiology 1.Loss of internal sphincter (innervation) 2. Loss of anal transitional zone 3. loss of rectal compliance

Own Results 1978 – 1992 low anterior resections n = 2707 coloanal anastomosis n = 103 (3,8 %) Male = 75, female = 28 Age 58,6 ( m = 59,8, f = 57,4) Rectal cancer n =88 Large adenomas n =9 Rectovaginal fistula after radiotherapy n = 6

summary Final evaluation for functional outcome makes sense only after 2 years. Subjective outcome in our series –80,6 % satisfied – 5,8 % not satisfied

Functional outcome CAAP ISR T ISR normal continence 73 %52 %51 % Incontinence for gas 6 %7 %3 % Minor incontinence 6 %26 %24 % Major incontinence 13 %11 %16 % colostomy2 %4 %5 % Good continence 79 %59 %54 % P = 0,02ns Bretagnol Dis Colon Rectum 2004

Summary functional outcome after ISR is acceptable Be aware of minor and major problems of incontinence in one third of the patients. Preoperative information about these problems are absolutely necessary Younger patients are more suitable for ISR. No good results will be achieved in older women Patient selection is the key to good functional results Avoid Creation of a perineal stoma

"Advance means progress to something better and not progress to something new." Sir Heneage Ogilivie ( Guy's Hospital London)

Thank you for your attention